Back to Search
Start Over
Chemotherapy-Induced Splenic Volume Increase Is Independently Associated with Major Complications after Hepatic Resection for Metastatic Colorectal Cancer
- Source :
- Journal of the American College of Surgeons. 220:271-280
- Publication Year :
- 2015
- Publisher :
- Ovid Technologies (Wolters Kluwer Health), 2015.
-
Abstract
- In patients with colorectal cancer liver metastases (CRCLM), chemotherapy-induced hepatic injury is associated with increased splenic volume, thrombocytopenia, and decreased long-term survival. The current study investigates the relationship between change in splenic volume after preoperative chemotherapy and development of postoperative complications.The study group consisted of 80 patients who underwent resection of CRCLM; half received neoadjuvant chemotherapy for 6 months before resection (n = 40) and the other half did not (n = 40). The study group was compared with two control groups: a normal group composed of patients undergoing cholecystectomy for benign disease (n = 40) and a group of untreated, nonmetastatic colorectal cancer (CRC) patients (n = 40). Splenic volume was measured by CT/MRI volumetry. In the study group, the nontumoral liver was graded for steatosis and sinusoidal injury; operative and outcomes characteristics were also analyzed.Before chemotherapy, CRCLM patients had normalized spleen volumes of 3.2 ± 1.1 mL/kg, significantly higher than normal (2.5 ± 0.8 mL/kg; p0.001) and nonmetastatic CRC (2.6 ± 1.3 mL/kg; p0.05) patients, with higher splenic volume after 6 months of chemotherapy (4.2 ± 1.7 mL/kg; p0.01). After chemotherapy, splenic volume increase was associated with any perioperative complication (p0.01) and major complications (p0.05). Patients with ≥39% splenic volume increase (maximal chi-square test) were significantly more likely to have major complications (p0.01). Spleen volume changes were not correlated with change in platelet count (R(2) = 0.03; p = 0.301).In patients with CRCLM, the presence of liver metastases and chemotherapy are associated with higher splenic volume. Percent splenic volume increase after 6 months of chemotherapy can aid preoperative risk stratification, as it was an independent predictor of major postoperative complications.
- Subjects :
- Adult
Male
medicine.medical_specialty
Colorectal cancer
medicine.medical_treatment
Antineoplastic Agents
Gastroenterology
Article
Postoperative Complications
Risk Factors
Internal medicine
Antineoplastic Combined Chemotherapy Protocols
Hepatectomy
Humans
Medicine
Single-Blind Method
Aged
Retrospective Studies
Aged, 80 and over
Body surface area
Chemotherapy
business.industry
Liver Neoplasms
Case-control study
Retrospective cohort study
Middle Aged
medicine.disease
Neoadjuvant Therapy
Surgery
Treatment Outcome
Chemotherapy, Adjuvant
Case-Control Studies
Splenomegaly
Female
Cholecystectomy
Steatosis
Colorectal Neoplasms
business
Follow-Up Studies
Subjects
Details
- ISSN :
- 10727515
- Volume :
- 220
- Database :
- OpenAIRE
- Journal :
- Journal of the American College of Surgeons
- Accession number :
- edsair.doi.dedup.....62216a8d4e7754954009e444e3d67356
- Full Text :
- https://doi.org/10.1016/j.jamcollsurg.2014.12.008